Together, we will find new cures for breast cancer
More than 319,000 people in the United States are expected to be diagnosed with breast cancer this year. For these people and those who love them, cures can’t come soon enough. Thanks to your donations, MSK is working toward a future with more hope and better outcomes for every person with breast cancer.
Your support fuels breakthroughs
Thanks to the support of our donor community, MSK is on the leading edge of breast cancer research and treatment. That’s why U.S. News and World Report ranked us the #2 cancer hospital in the country and why Charity Navigator gave us its highest rating.
We’ve made considerable progress in treating breast cancer
Donations from our community have enabled MSK’s many trailblazing breast cancer advances:
- The first targeted drug, trastuzumab deruxtecan (Enhertu®), to treat HER2-low breast cancer
- A new FDA-approved treatment for people with ER positive, HER2 negative advanced breast cancer that has become resistant to standard therapy
- Genetic testing and targeted treatment based on results obtained through our tumor-sequencing test MSK-IMPACT®
And we’re creating even more hope for tomorrow
Your gift will fund the next wave of breast cancer discoveries and accelerate today's breakthroughs, such as:
- Cryoablation, a promising approach for patients who are not candidates for surgery
- T cell receptor therapy, a new approach to immunotherapy that targets cancer cells from the inside out
Make a gift in honor or memory of a loved one and get 3X matched during Breast Cancer Awareness Month.
The people your gift has helped
The impact of the MSK Giving community
Uniting experts
The pioneering Evelyn H. Lauder Breast Center at MSK — established in 2009 with a $50 million gift from the Leonard and Evelyn Lauder Foundation — helped set a new standard for breast cancer care worldwide.
Learn moreServing our communities
For more than two decades, the MSK Ralph Lauren Center has been a beacon for accessibility and high-quality cancer care in Harlem, providing the community with lifesaving prevention and treatment services, including mammograms.
Read moreAccelerating progress
When Rebecca Timlin-Scalera, PhD, was diagnosed with metastatic breast cancer, she was surprised to learn how little research funding was dedicated to the disease. The Cancer Couch Foundation is her legacy and aims to flip the script.
Support the Cancer CouchFulfilling a legacy
After Ruth Sussman died at just 46 years old, her family began supporting breast cancer research at MSK in her memory. Their continued dedication helps fuel new breakthroughs and brings hope to families facing breast cancer.
See the impactSupport innovative research and get 3X matched during Breast Cancer Awareness Month.
